This inventor holds 1 USPTO granted patent. Top assignee: Wockhardt Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Sudhir Shengule: Innovator in Bacterial Infection Treatment
Introduction
Sudhir Shengule is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating bacterial infections. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Sudhir Shengule holds a patent for "7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide containing compounds and their use in treating bacterial infections." This patent discloses compounds of Formula (I), their preparation, and their application in preventing or treating bacterial infections. His work in this area highlights the potential for new therapeutic options in combating resistant bacterial strains.
Career Highlights
Sudhir Shengule is associated with Wockhardt Limited, a prominent pharmaceutical company known for its commitment to research and development. His role at Wockhardt has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medicinal chemistry.
Collaborations
Some of his notable coworkers include Vijaykumar Jagdishwar Patil and Mangesh Pawar. Their collective efforts in research and development have fostered an environment of innovation and creativity within the company.
Conclusion
Sudhir Shengule's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for compounds aimed at treating bacterial infections represents a significant advancement in medical science. Through his career at Wockhardt Limited, he continues to contribute to the fight against bacterial diseases, showcasing the importance of research and collaboration in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
